To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects
type: MedicalStudy
description: A Phase 1, Single-center, Placebo-controlled, Double-blind, Randomized Trial to Assess the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of ACH-000029 in Healthy Subjects
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2022-05-06
end date: 2022-11-02
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT05363839
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Syneos Health
study subject: Healthy Volunteers
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Healthy Volunteers

AI Analytics
type: Organization